{"id":323197,"date":"2024-07-10T00:00:00","date_gmt":"2024-07-10T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidop0023-biopharma-retinitis-pigmentosa-epidemiology-epidemiology-retinitis-pigmentosa\/"},"modified":"2026-04-22T05:13:40","modified_gmt":"2026-04-22T05:13:40","slug":"epidop0023-biopharma-retinitis-pigmentosa-epidemiology-epidemiology-retinitis-pigmentosa-mature-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidop0023-biopharma-retinitis-pigmentosa-epidemiology-epidemiology-retinitis-pigmentosa-mature-markets\/","title":{"rendered":"Retinitis Pigmentosa &#8211; Epidemiology &#8211; Epidemiology &#8211; Retinitis Pigmentosa &#8211; Mature Markets"},"content":{"rendered":"<p>Clarivate Epidemiology&#8217;s coverage of retinitis pigmentosa comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of retinitis pigmentosa for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan in this report.<\/p>\n<p>Clarivate Epidemiology&#8217;s retinitis pigmentosa forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people diagnosed with retinitis pigmentosa, how many in each country in the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of retinitis pigmentosa over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate\u2019s Epidemiology provides at least ten years of forecast data for the following retinitis pigmentosa\u00a0patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed inherited retinal dystrophy prevalent cases<\/li>\n<li>Diagnosed retinitis pigmentosa prevalent cases<\/li>\n<li>Diagnosed drug-treated cases of retinitis pigmentosa<\/li>\n<li>Clinical subtypes of retinitis pigmentosa<\/li>\n<li>Diagnosed Usher syndrome prevalent cases<\/li>\n<li>Diagnosed Bardet-Biedl syndrome prevalent cases<\/li>\n<li>Diagnosed prevalent cases with <abbr title=\"retinal pigment epithelium 65\">RPE65<\/abbr>\u00a0mutation<\/li>\n<li>Diagnosed prevalent cases with RHO mutation<\/li>\n<li>Diagnosed Leber&#8217;s congenital amaurosis prevalent cases<\/li>\n<li>Diagnosed choroideremia prevalent cases<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-323197","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-ophthalmology","biopharma-therapy-areas-retinitis-pigmentosa","biopharma-product-epidemiology","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/323197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/323197\/revisions"}],"predecessor-version":[{"id":323547,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/323197\/revisions\/323547"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=323197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}